Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
| ▸ | KDM4A | O75164 | 8/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 8/20 | 0.38 |
| ▸ | KDM5A | P29375 | 1/20 | 0.38 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.38 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9353528 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL9162411 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL9160212 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL9432308 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL9353551 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL16945134 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL9162783 | 1.00 | ALDH1A1 (0.58) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL1049266 | 0.97 | ALDH1A1 (0.61) | ALDH1A1GPR84FFAR1FFAR4CHRNB2 | |
| SCHEMBL96642 | 0.90 | — | — | |
| SCHEMBL3189950 | 0.89 | ALDH1A1 (0.70) | ALDH1A1CHRNB2CHRNB4CHRNA4HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0413006-B1 | HYDROXYALKANE CARBOXYLIC ACID DERIVATES AND THEIR USE | SCHERING AG (DE) | 1994-10-19 | — | — | EP | claimed |
| EP-0612719-A1 | Hydroxyalkanecarboxylic acid derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-08-31 | — | — | EP | claimed |
| EP-0571062-A1 | Hydroxyalkylcarboxylic acid derivatives, their preparation and use | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-11-24 | — | — | EP | claimed |
| US-5089175-A | Treatment of disorders of skin and mucous membranes | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-02-18 | — | — | US | claimed |
| EP-0413006-A1 | HYDROXYALKANE CARBOXYLIC ACID DERIVATES AND THEIR USE. | SCHERING AG (DE) | 1991-02-20 | — | — | EP | claimed |
| WO-1990009373-A1 | HYDROXYALKANE CARBOXYLIC ACID DERIVATES, THEIR MANUFACTURE AND USE | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-08-23 | — | — | WO | claimed |
| EP-2841109-B1 | PRODRUGS OF HYDROXYL-COMPRISING DRUGS | ASCENDIS PHARMA AS (DK) | 2026-04-15 | — | — | EP | disclosed |
| WO-2025129358-A1 | STABLE FILM FORMULATIONS FOR HIGH LOADING OF LOW MELTING POINT ACTIVES | INTELGENX CORP. (CA) | 2025-06-26 | — | — | WO | disclosed |
| EP-3782649-B1 | BIODEGRADABLE POLYETHYLENE GLYCOL BASED WATER-INSOLUBLE HYDROGELS | ASCENDIS PHARMA AS (DK) | 2025-05-14 | — | — | EP | disclosed |
| CN-114605329-B | Substituted indazole carboxamides or substituted azaindazole carboxamides FLT3 inhibitors and uses thereof | 河南中医药大学 | 2024-01-26 | — | — | CN | disclosed |
| US-20230381323-A1 | RELEASABLE CONJUGATES | FISH & RICHARDSON PC | 2023-11-30 | — | — | US | disclosed |
| US-11786599-B2 | Releasable conjugates | QUIAPEG PHARMACEUTICALS AB (SE) | 2023-10-17 | — | — | US | disclosed |
| US-20230123784-A1 | Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels | ASCENDIS PHARMA A/S (DK) | 2023-04-20 | — | — | US | disclosed |
| EP-0413006-B1 | HYDROXYALKANE CARBOXYLIC ACID DERIVATES AND THEIR USE | SCHERING AG (DE) | 1994-10-19 | — | — | EP | disclosed |
| EP-0612719-A1 | Hydroxyalkanecarboxylic acid derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-08-31 | — | — | EP | disclosed |
| EP-0571062-A1 | Hydroxyalkylcarboxylic acid derivatives, their preparation and use | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-11-24 | — | — | EP | disclosed |
| WO-1993022278-A1 | PROCESS FOR PRODUCING HYDROXYALKANE CARBOXYLIC ACID AMIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-11-11 | — | — | WO | disclosed |
| US-5089175-A | Treatment of disorders of skin and mucous membranes | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-02-18 | — | — | US | disclosed |
| EP-0413006-A1 | HYDROXYALKANE CARBOXYLIC ACID DERIVATES AND THEIR USE. | SCHERING AG (DE) | 1991-02-20 | — | — | EP | disclosed |
| WO-1990009373-A1 | HYDROXYALKANE CARBOXYLIC ACID DERIVATES, THEIR MANUFACTURE AND USE | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230123784-A1 | Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels | PLG, PHYKPL, PLOD3 | ALDH1A1 1053/4885GPR84 1029/4885FFAR1 1930/4885 |
| US-20230381323-A1 | RELEASABLE CONJUGATES | GUSB, ABCB11, UGT2B7 | ALDH1A1 72/4885GPR84 2749/4885FFAR1 1513/4885 |
| US-11786599-B2 | Releasable conjugates | GUSB, ABCB11, UGT2B7 | ALDH1A1 72/4885GPR84 2749/4885FFAR1 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.